Codis Revolutionizes Spray Drying with New Global CDMO Services
Codis Emerges as a New Leader in Global CDMO Services
Introducing a pioneering global CDMO that merges advanced spray drying and particle engineering technologies under a unified brand.
Formation and Specialization of Codis
Codis has recently launched as a prominent global Contract Development and Manufacturing Organization (CDMO). This innovative company specializes in commercial-scale spray drying and amorphous solid dispersions (ASD), bringing together industry expertise and cutting-edge technology.
Origins and Integration
The establishment of Codis is a significant milestone, resulting from the integration of two industry leaders: Particle Dynamics and the former spray drying facility previously operated by EUROAPI in Haverhill, UK. This strategic union combines years of resourcefulness and regulatory acumen, laying a solid foundation for future endeavors.
Service Offerings and Capabilities
With extensive facilities located in St. Louis, Seymour, and Haverhill, Codis stands out for its impressive output capabilities:
- Annual output exceeding 5000 metric tons of spray drying capacity.
- A diverse product portfolio featuring 30 distinct products catering to over 50 pharmaceutical customers worldwide.
- A remarkable 30-year track record in navigating regulatory landscapes successfully.
- Rigorous auditing and approval from six renowned international regulatory bodies.
- A dedicated workforce of over 300 employees contributing to various aspects of operations.
Core Values and Strategic Direction
The guiding philosophy of Codis, as articulated by CEO Nicolas Fortin, emphasizes growth through scale, quality, and a broad-reaching global presence. With operations encompassing 40,000 m2 of state-of-the-art manufacturing space and multiple GMP-approved facilities, Codis is strategically positioned to expedite the path for pharmaceutical developers seeking to bring their innovations to market.
Expertise in Regulatory Compliance
Acquired from EUROAPI in mid-2025, the Haverhill site brings along a rich legacy of excellence in spray drying, continuous flow chemistry processes, and regulatory compliance. This pivotal facility also plays a crucial role as a leading manufacturer of Sevelamer, highlighting its capacity to support high-quality products that meet global regulatory standards.
The Codis Identity and Mission
The name Codis, which draws from the Latin word codex, meaning "law" or "system", encapsulates the company’s overarching commitment to compliance, reliability, and effective problem-solving for its global partners.
About Codis
Codis stands out in the CDMO landscape, specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and the manufacturing of finished dosage forms across pharmaceutical, consumer health, nutraceutical, and OTC sectors.
Key Strengths of Codis
Codis prides itself on delivering exceptional capabilities:
- A substantial GMP spray drying capacity, among the largest in the industry.
- A proven record of achieving regulatory approvals across prominent agencies such as the FDA, EMA, and PMDA.
- Recognition as a trusted partner by top-tier pharmaceutical companies globally.
Frequently Asked Questions
What services does Codis provide as a CDMO?
Codis offers specialized services in commercial spray drying, amorphous solid dispersions, and particle engineering, catering to the pharmaceutical sector.
How was Codis formed?
Codis was formed through the integration of Particle Dynamics and the former EUROAPI facility in Haverhill, UK, combining extensive expertise and technology.
What is Codis’s manufacturing capacity?
Codis has an output capacity exceeding 5000 metric tons per year, demonstrating significant capability in commercial-scale production.
Where are Codis’s facilities located?
Codis operates facilities in St. Louis, Missouri, Seymour, Indiana, and Haverhill, UK, each equipped for advanced manufacturing processes.
What does Codis aim to achieve?
Codis aims to accelerate the development of pharmaceutical therapies, emphasizing quality, compliance, and global reach in its operations.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.